Medicine and Dentistry
Thrombosis
100%
Prematurity
100%
Iliac Artery
100%
Triphenyltetrazolium
100%
Fibrinolytic Therapy
100%
Single Umbilical Artery
75%
Alteplase
50%
Thromboembolism
50%
Artery Thrombosis
50%
Neonatal Infant
25%
Pediatrics
25%
Clinical Trial
25%
Limb
25%
Disease Course
25%
Pelvis
25%
Cardiac Catheterization
25%
Pharmacokinetics
25%
Blood Clot Lysis
25%
Cesarean Section
25%
Neonate
25%
Chromosome Aberration
25%
Controlled Clinical Trial
25%
Thrombolytic Drug
25%
Antithrombotic Therapy
25%
Femoral Artery
25%
Blood Pressure Monitoring
25%
Arterial Catheter
25%
Invasive Blood Pressure
25%
Prothrombin G20210A
25%
Central Venous Catheter
25%
Diseases
25%
Keyphrases
Thrombosis
100%
Iliac Artery
100%
Recombinant Tissue Plasminogen Activator (rt-PA)
100%
Thrombolytic Therapy
100%
Preterm Neonates
100%
Single Umbilical Artery
50%
Arterial Thrombosis
33%
Controlled Experiment
16%
Clinical Trials
16%
Severe Disease
16%
High Risk
16%
Clinical Course
16%
Pelvis
16%
Pharmacokinetics
16%
Neonate
16%
Increased Incidence
16%
Antithrombotic Therapy
16%
Cesarean Section (C-section)
16%
Pediatric Population
16%
Chromosomal Abnormalities
16%
Femoral Artery
16%
Prothrombin G20210A mutation
16%
Hypoplastic
16%
Central Venous Line
16%
Arterial Catheter
16%
Thrombolysis
16%
Cardiac Catheterization
16%
Structural Anomalies
16%
Gestational Week
16%
Limb Loss
16%
Organ Loss
16%
Invasive Blood Pressure Monitoring
16%
Thrombolytic Agents
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prematurity
100%
Fibrinolytic Agent
100%
Triphenyltetrazolium
100%
Thrombosis
100%
Single Umbilical Artery
75%
Thromboembolism
50%
Artery Thrombosis
50%
Alteplase
50%
Clinical Trial
25%
Controlled Clinical Trial
25%
Antithrombotic Therapy
25%
Disease Course
25%
Prothrombin
25%
Chromosome Aberration
25%
Pharmacokinetics
25%
Diseases
25%
Biochemistry, Genetics and Molecular Biology
Tissue Plasminogen Activator
100%
Dynamics
50%
Clinical Trial
50%
Controlled Clinical Trial
50%
Chromosomal Disorder
50%
Prothrombin G20210A
50%
Invasive Blood Pressure
50%
Blood Clot Lysis
50%
Pharmacokinetics
50%
Immunology and Microbiology
Umbilical Artery
100%
Iliac Artery
100%
Dynamics
33%
Blood Pressure
33%
Limb
33%
Blood Clot Lysis
33%
Pharmacokinetics
33%
Pelvis
33%
Femoral Artery
33%